Abrégé

The present invention relates to the pharmaceutical and nutraceutical fields and, more specifically, to a composition comprising an extract from a combination of plants for the prevention and/or treatment of a neurodegenerative disease

Classes IPC  ?

• A61K 36/61 - Myrtaceae (famille du myrte), p. ex. cajeputier ou eucalyptus
• A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée
• A61K 36/324 - Boswellia, p. ex. encens
• A61K 36/54 - Lauraceae (famille du laurier), p. ex. cannelle ou sassafras
• A61K 36/835 - Aquilaria
• A61K 36/8905 - Cyperus (Cyperus iria)
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence

Produits et services

Chemical food additives; chemical seasonings (for use in the food industry); chemical food preservatives; chemical substances used as food ingredients; plant extracts for the food industry. Food supplements and dietetic preparations; nutraceutical preparations for therapeutic or medical use; nutraceutical products used as dietary supplements; nutraceuticals for humans; bark extracts for nutraceutical use; food supplements with cosmetic effect; dietary supplement beverage mixes.

Abrégé

The present invention relates to the pharmaceutical and nutraceutical fields and, more specifically, to a composition comprising an extract from a combination of plants for the prevention and/or treatment of a neurodegenerative disease

Classes IPC  ?

• A61K 36/61 - Myrtaceae (famille du myrte), p. ex. cajeputier ou eucalyptus
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
• A61K 36/185 - Magnoliopsida (dicotylédones)
• A61K 36/285 - Aucklandia
• A61K 36/324 - Boswellia, p. ex. encens
• A61K 36/54 - Lauraceae (famille du laurier), p. ex. cannelle ou sassafras
• A61K 36/835 - Aquilaria
• A61K 36/8905 - Cyperus (Cyperus iria)
• A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée

Produits et services

Chemical additives for food; Chemical seasonings [for food manufacture]; Food preservative compositions; Chemical substances for use as food ingredients; Plant extracts for use in the manufacture of food. Dietary supplements and dietetic preparations; Nutraceutical preparations for therapeutic or medical purposes; Nutraceuticals for use as a dietary supplement; Nutraceuticals for human beings; Bark extract for nutraceutical use; Dietary supplements with a cosmetic effect; Drink mixes, for use in the following fields: Food supplements.

Produits et services

Chemical food additives for use in the manufacture of food; plant extracts for the food industry Food supplements and dietetic preparations adapted for medical purposes; nutraceutical preparations for therapeutic and medical use; nutraceutical preparations used as dietary supplements; nutraceuticals for use as a dietary supplement for humans; bark extracts containing sandalwood bark and eaglewood bark for nutraceutical use; dietary food supplements with cosmetic effect; dietary supplement beverage mixes for human consumption in liquid and dry mix form for therapeutic purposes